Li ZY - Search Results

1

Inhibition of lymphatic metastases by a survivin dominant-negative mutant.

Xu GC, Zhang P, Leng F, Pan L, Li ZY, Yu DD, Shan Y, Yuan QZ, Wen Y, Mu B, Shi HS, Chen X, Wang CT. Xu GC, et al. Among authors: li zy. Oncol Res. 2012;20(12):579-87. doi: 10.3727/096504013X13775486749416. Oncol Res. 2012. PMID: 24139416

2

Inhibition of human lung adenocarcinoma growth using survivint34a by low-dose systematic administration.

Shan Y, Wang C, Yang L, Chen LJ, Deng HX, Yang HS, Li Z, Li Z, Pan L, Leng F, Wei Y. Shan Y, et al. J Biosci. 2010 Jun;35(2):209-16. doi: 10.1007/s12038-010-0025-3. J Biosci. 2010. PMID: 20689177

3

[Anti-prostate cancer activity of Survivin-T34A mutant in vitro and in vivo].

Pan L, Peng XC, Yuan QZ, Leng F, Yu DD, Shan Y, Li ZY, Wang CT. Pan L, et al. Among authors: li zy. Sichuan Da Xue Xue Bao Yi Xue Ban. 2010 May;41(3):390-3. Sichuan Da Xue Xue Bao Yi Xue Ban. 2010. PMID: 20629305 Chinese.

4

[Therapeutic effects of survivinT34A mutants on pulmonary metastases of melanoma B16 in mice].

Zhang L, Li ZY, Wang CT. Zhang L, et al. Among authors: li zy. Sichuan Da Xue Xue Bao Yi Xue Ban. 2011 May;42(3):313-6. Sichuan Da Xue Xue Bao Yi Xue Ban. 2011. PMID: 21826989 Chinese.

5

Enhanced tumor radiosensitivity by a survivin dominant-negative mutant.

Yuan QZ, Wang CT, Mao YQ, Zhang P, Shi HS, Li ZY, Pan L, Yu DD, Leng F, Chen X, Ying W, Xu JH, Li W, Wu F, Wen Y, Ma TT, Wei YQ. Yuan QZ, et al. Among authors: li zy, li w. Oncol Rep. 2010 Jan;23(1):97-103. Oncol Rep. 2010. PMID: 19956869

6

Therapeutic effects of survivin dominant negative mutant in a mouse model of prostate cancer.

Pan L, Peng XC, Leng F, Yuan QZ, Shan Y, Yu DD, Li ZY, Chen X, Xiao WJ, Wen Y, Ma TT, Yang L, Mao YQ, Yang HS, Wei YQ, Wang CT. Pan L, et al. Among authors: li zy. J Cancer Res Clin Oncol. 2011 Jan;137(1):19-28. doi: 10.1007/s00432-010-0855-2. Epub 2010 Mar 9. J Cancer Res Clin Oncol. 2011. PMID: 20217127

7

Enhancement of cisplatin sensitivity in Lewis Lung carcinoma by liposome-mediated delivery of a survivin mutant.

Yu DD, Wang CT, Shi HS, Li ZY, Pan L, Yuan QZ, Leng F, Wen Y, Chen X, Wei YQ. Yu DD, et al. Among authors: li zy. J Exp Clin Cancer Res. 2010 May 12;29(1):46. doi: 10.1186/1756-9966-29-46. J Exp Clin Cancer Res. 2010. PMID: 20462440 Free PMC article.

8

The antitumor and antimetastatic effects of N-trimethyl chitosan-encapsulated camptothecin on ovarian cancer with minimal side effects.

Zhou L, Du L, Chen X, Li X, Li Z, Wen Y, Li Z, He X, Wei Y, Zhao X, Qian Z. Zhou L, et al. Oncol Rep. 2010 Oct;24(4):941-8. doi: 10.3892/or.2010.941. Oncol Rep. 2010. PMID: 20811674

9

Short hairpin RNA targeting of fibroblast activation protein inhibits tumor growth and improves the tumor microenvironment in a mouse model.

Cai F, Li Z, Wang C, Xian S, Xu G, Peng F, Wei Y, Lu Y. Cai F, et al. BMB Rep. 2013 May;46(5):252-7. doi: 10.5483/bmbrep.2013.46.5.172. BMB Rep. 2013. PMID: 23710635 Free PMC article.

10

Immunotherapy targeting fibroblast activation protein inhibits tumor growth and increases survival in a murine colon cancer model.

Wen Y, Wang CT, Ma TT, Li ZY, Zhou LN, Mu B, Leng F, Shi HS, Li YO, Wei YQ. Wen Y, et al. Among authors: li zy, li yo. Cancer Sci. 2010 Nov;101(11):2325-32. doi: 10.1111/j.1349-7006.2010.01695.x. Cancer Sci. 2010. PMID: 20804499 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,112 results

Search Page

Filters